{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:32:40Z","timestamp":1774438360754,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.ando.2012.03.036","type":"journal-article","created":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T10:29:17Z","timestamp":1335263357000},"page":"107-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Traitement de la maladie de Cushing\u00a0: progr\u00e8s r\u00e9cents"],"prefix":"10.1016","volume":"73","author":[{"given":"Xavier","family":"Bertagna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Guignat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2012.03.036_bib0005","series-title":"The Pituitary","first-page":"533","article-title":"Cushing's disease","author":"Bertagna","year":"2011"},{"key":"10.1016\/j.ando.2012.03.036_bib0010","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing's syndrome","volume":"367","author":"Newell-Price","year":"2006","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ando.2012.03.036_bib0015","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.beem.2009.06.001","article-title":"Cushing's disease","volume":"23","author":"Bertagna","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ando.2012.03.036_bib0020","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1210\/jc.2007-2734","article-title":"Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement","volume":"93","author":"Biller","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ando.2012.03.036_bib0025","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1210\/jc.2009-0290","article-title":"Hypercoagulable state in Cushing's syndrome: a systematic review","volume":"94","author":"Van Zaane","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2012.03.036_bib0030","doi-asserted-by":"crossref","unstructured":"Stuijver DJ, van Zaane B, Feelders RA, Debeij J, Cannegieter SC, Hermus AR, et al. Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort study. J Clin Endocrinol Metab 2011.","DOI":"10.1210\/jc.2011-1661"},{"issue":"5","key":"10.1016\/j.ando.2012.03.036_bib0035","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/EJE-10-0583","article-title":"Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after surgery","volume":"163","author":"Manetti","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"10.1016\/j.ando.2012.03.036_bib0040","first-page":"3662","article-title":"Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome","volume":"87","author":"Boscaro","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ando.2012.03.036_bib0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/EJE-07-0514","article-title":"Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease","volume":"158","author":"Castinetti","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2012.03.036_bib0050","unstructured":"Baudry C, Coste J, Bou Khalil R, Guignat L, Abbas H, Guibourdenche J, et al. Results of O,p\u2019DDD treatment in 76\u00a0patients with Cushing's disease. Am Endo Soc Meeting 2011, Boston."},{"issue":"9","key":"10.1016\/j.ando.2012.03.036_bib0055","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1210\/jc.2011-0536","article-title":"Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome","volume":"96","author":"Kamenicky","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ando.2012.03.036_bib0060","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1210\/jcem-61-3-536","article-title":"Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486","volume":"61","author":"Nieman","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ando.2012.03.036_bib0065","first-page":"3568","article-title":"Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486)","volume":"86","author":"Chu","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ando.2012.03.036_bib0070","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/BF03350817","article-title":"Treatment of severe psychosis due to ectopic Cushing's syndrome","volume":"30","author":"Belgian","year":"2007","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"10.1016\/j.ando.2012.03.036_bib0075","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1530\/EJE-09-0098","article-title":"Merits and pitfalls of mifepristone in Cushing's syndrome","volume":"160","author":"Castinetti","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.ando.2012.03.036_bib0080","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1210\/jcem-70-5-1426","article-title":"Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing's syndrome and dose-response relationship in normal subjects","volume":"70","author":"Schulte","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ando.2012.03.036_bib0085","first-page":"4104","article-title":"Use of a parenteral propylene glycol-containing etomidate preparation for the long-term management of ectopic Cushing's syndrome","volume":"86","author":"Krakoff","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ando.2012.03.036_bib0090","first-page":"3542","article-title":"Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing's syndrome and peritonitis","volume":"83","author":"Drake","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ando.2012.03.036_bib0095","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1097\/PCC.0b013e318198b096","article-title":"A novel use of etomidate for intentional adrenal suppression to control severe hypercortisolemia in childhood","volume":"10","author":"Mettauer","year":"2009","journal-title":"Pediatr Crit Care Med"},{"issue":"5","key":"10.1016\/j.ando.2012.03.036_bib0100","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00268-007-9387-6","article-title":"Surgery for Cushing's syndrome: an historical review and recent 10-year experience","volume":"32","author":"Porterfield","year":"2008","journal-title":"World J Surg"},{"issue":"4","key":"10.1016\/j.ando.2012.03.036_bib0105","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2265.2007.03082.x","article-title":"Bilateral laparoscopic adrenalectomy for corticotrophin-dependent Cushing's syndrome: a review of the Mayo Clinic experience","volume":"68","author":"Chow","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.ando.2012.03.036_bib0110","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jamcollsurg.2009.02.054","article-title":"Bilateral adrenalectomy for refractory Cushing disease: a safe and definitive therapy","volume":"208","author":"Smith","year":"2009","journal-title":"J Am Coll Surg"},{"issue":"1","key":"10.1016\/j.ando.2012.03.036_bib0115","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1210\/jc.2006-1328","article-title":"Corticotroph tumor progression after adrenalectomy in Cushing's disease: a reappraisal of Nelson's syndrome","volume":"92","author":"Assi\u00e9","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ando.2012.03.036_bib0120","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11102-005-1403-y","article-title":"The Nelson's syndrome\u2026 revisited","volume":"7","author":"Assi\u00e9","year":"2004","journal-title":"Pituitary"},{"issue":"3","key":"10.1016\/j.ando.2012.03.036_bib0125","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3171\/foc.2007.23.3.14","article-title":"Nelson syndrome: historical perspectives and current concepts","volume":"23","author":"Hornyak","year":"2007","journal-title":"Neurosurg Focus"},{"issue":"5","key":"10.1016\/j.ando.2012.03.036_bib0130","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrendo.2011.12","article-title":"Management of Cushing disease","volume":"7","author":"Tritos","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ando.2012.03.036_bib0220","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nrendo.2012.20","article-title":"Pituitary function: Cushing disease-long-term outcome after transsphenoidal surgery","volume":"8","author":"Wilson","year":"2012","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"10.1016\/j.ando.2012.03.036_bib0140","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1210\/jc.2003-031908","article-title":"Pituitary magnetic resonance imaging findings do not influence surgical outcome in adrenocorticotropin-secreting microadenomas","volume":"89","author":"Salenave","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ando.2012.03.036_bib0145","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1227\/NEU.0b013e31822dda2c","article-title":"Transsphenoidal surgery for Cushing disease: experience with 136\u00a0patients","volume":"70","author":"Ciric","year":"2012","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ando.2012.03.036_bib0150","doi-asserted-by":"crossref","unstructured":"Yamada S, Fukuhara N, Nishioka H, Takeshita A, Inoshita N, Ito J, et al. Surgical management and outcomes in patients with cushing disease with negative pituitary magnetic resonance imaging. World Neurosurg 2011, on line e-pubmed.","DOI":"10.1016\/j.wneu.2011.06.033"},{"issue":"3","key":"10.1016\/j.ando.2012.03.036_bib0155","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3171\/foc.2007.23.3.4","article-title":"Evaluation and management of Cushing syndrome in cases of negative sellar magnetic resonance imaging","volume":"23","author":"Jagannathan","year":"2007","journal-title":"Neurosurg Focus"},{"issue":"9","key":"10.1016\/j.ando.2012.03.036_bib0160","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1210\/jc.2008-2772","article-title":"Long-term results of stereotactic radiosurgery in secretory pituitary adenomas","volume":"94","author":"Castinetti","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2012.03.036_bib0165","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1210\/jc.2008-1533","article-title":"The medical treatment of Cushing's disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery","volume":"94","author":"Pivonello","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2012.03.036_bib0170","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/jc.2008-1008","article-title":"Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial","volume":"94","author":"Boscaro","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2012.03.036_bib0175","unstructured":"Colao AM, et al. The 93rd Annual Meeting. Am Endo Soc Meeting 2011."},{"issue":"11","key":"10.1016\/j.ando.2012.03.036_bib0180","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/nm784","article-title":"Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas","volume":"8","author":"Heaney","year":"2002","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.ando.2012.03.036_bib0185","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2265.2005.02193.x","article-title":"Preoperative medical therapy with rosiglitazone in two patients with newly diagnosed pituitary-dependent Cushing's syndrome","volume":"62","author":"Hull","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.ando.2012.03.036_bib0190","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/eje.0.1510173","article-title":"Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease","volume":"151","author":"Ambrosi","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.ando.2012.03.036_bib0195","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1055\/s-2007-970162","article-title":"Long-term treatment of central Cushing's syndrome with rosiglitazone","volume":"115","author":"Morcos","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"12","key":"10.1016\/j.ando.2012.03.036_bib0200","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1172\/JCI60417","article-title":"EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas","volume":"121","author":"Fukuoka","year":"2011","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.ando.2012.03.036_bib0205","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1172\/JCI11098","article-title":"Retinoic acid prevents experimental Cushing syndrome","volume":"108","author":"P\u00e1ez-Pereda","year":"2001","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.ando.2012.03.036_bib0210","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1210\/jc.2010-0644","article-title":"Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience","volume":"95","author":"Raverot","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ando.2012.03.036_bib0215","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1227\/NEU.0b013e318230ac63","article-title":"Cusimano M.O-6-Methylguanine-DNA methyltransferase (MGMT) immunohistochemical expression in pituitary corticotroph adenomas","volume":"70","author":"Salehi","year":"2012","journal-title":"Neurosurgery"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426612000601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426612000601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:44:37Z","timestamp":1757717077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426612000601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0003426612000601"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2012.03.036","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traitement de la maladie de Cushing\u00a0: progr\u00e8s r\u00e9cents","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2012.03.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}